The European Biosafety Association (EBSA) welcomes the European Biotech Act I as a significant initiative towards strengthening the biotechnology ecosystem in Europe, taking note of its focus on health biotechnology as an initialstep.
EBSA ivzw
Industry association · Belgium · EU Transparency Register 194518991651-02
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 784 non-governmental organisations on this site, they rank #189 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- We are member of IFBA (International Federation of Biosafety Associations)
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Non-governmental organisations
- Registered as
- European Biosafety Association (EBSA ivzw)
- Head office
- Gentbrugge, Belgium
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track EBSA in PolicySpeak: request access →
Work at EBSA ivzw? so we know who speaks for it.
Their record over time
EBSA ivzw filed 4 positions between 27 May 2025 and 9 Jun 2026, across 3 of the 326 legislative files tracked here, attaching a full position paper 4 times.
What they argued
The European Biosafety Association (EBSA) is an organisation representing biosafety and biosecurity professionals, as well as those in aligned fields. It serves as a platform for specialists across Europe and beyond to share knowledge, collaborate, and promote best practices. EBSA's 600+ members represent 45 countries and include experts from academic, clinical, governmental and industrial environments.
The European Biosafety Association (EBSA) takes note of the European Commissions initiative to prepare a Biotech Act II focusing on industrial biotechnology and biomanufacturing. The Biotech Act II is expected to complement the European Biotech Act I, which focuses primarily on health biotechnology and is currently progressing through the legislative process.
The European Biosafety Association (EBSA) welcomes the Call for Evidence on the European Innovation Act. Detailed feedback can be found in the attached position paper. For ease of reference, the executive summary is copied here below. EBSA remains fully available to engage further on any of the points outlined in this document.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- Danish Industry · 3 files in common
- German Association of Biotechnology Industries (DIB) within the German Chemical Industry Association - VCI · 3 files in common
- BASF SE · 3 files in common
- Eurogroup for Animals · 3 files in common
- EFPIA · 3 files in common
Showing 5 of 96.
Is this your organization?
Everything on this page comes from EBSA ivzw’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.